A government official in Sierra Leone says that some people are recovering from Ebola because of a new treatment. The Minister of Information Alpha Kanu recently wrote in a letter that “this works; people are getting better.” But efforts to get this information and the treatment itself to people have met with great opposition on the part of the United States FDA and others. At this point, every option to treat Ebola, both pharmaceutical and natural, remains experimental. So why is this one option being met with so much resistance?
The option that has Kanu’s enthusiastic approval is a nutrient that is not manufactured by a big-name pharmaceutical company. It is called Nano Silver, in a 10 parts-per-million solution, made by the non-profit Natural Solutions Foundation. But it has not been easy to get the product to the countries that need it most.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
According to a statement by NSF’s Medical Director Dr. Rima Laibow, a shipment of the product was shipped to Sierra Leone on August 20. However, it didn’t arrive until “September 28, 5 weeks later while the disease spread and people suffered and died unnecessarily because international forces opposed the simple clinical demonstration of the nutrient.” The shipment follows a statement made by the World Health Organization on August 12, reported by Mashable, that acknowledges that there is not yet a proven treatment, but even unproven options should be made available to people afflicted with Ebola.
“In the particular circumstances of this outbreak, and provided certain conditions are met, the panel reached consensus that it is ethical to offer unproven interventions with as yet unknown efficacy and adverse effects, as potential treatment or prevention.”
Latest posts by Niamh Harris (see all)
- Democrats Reinstall Fence Around Capitol Ahead Of Biden’s State of Union - February 7, 2023
- Ireland To Promote Diversity & Drag Queens During St Patrick’s Day Celebrations - February 7, 2023
- California Drops Plan For Children’s Covid Jab Mandate - February 7, 2023